Mineralys Therapeutics (MLYS) Share-based Compensation (IS) (2022 - 2026)
Mineralys Therapeutics' Share-based Compensation (IS) came in at $7.88 million for Q3 2026, up 34.9% from $5.84 million a year earlier and up 7.1% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Share-based Compensation (IS) (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Mineralys Therapeutics reported Share-based Compensation (IS) of $27.07 million, up 57.6% year-over-year; for FY2025, it came in at $19.32 million, up 70.5% from FY2024.
- Share-based Compensation (IS) carries a three-year compound annual growth rate of 248.9% (FY2022 to FY2025).
- Going back by year, Share-based Compensation (IS) was $11.34 million in FY2024 (+124.0%), $5.06 million in FY2023 and $455,000 in FY2022.
- The Q3 2026 figure represents the highest quarterly Share-based Compensation (IS) in data going back to Q1 2022.
- Year-over-year, Share-based Compensation (IS) has increased for 13 consecutive quarters, with growth averaging 71.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Share-based Compensation (IS) ran from 34.9% in Q3 2026 to 721.9% in Q3 2023.
- Business Quant data shows MLYS's Share-based Compensation (IS) at $7.36 million (Q2 2026), $6.55 million (Q1 2026) and $5.29 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | - |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | - |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Mineralys Therapeutics | 1.42 Bn | -1.17 Bn | - | 7.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.88 Mn |
| Jun 30, 2026 | 7.36 Mn |
| Mar 31, 2026 | 6.55 Mn |
| Dec 31, 2025 | 5.29 Mn |
| Sep 30, 2025 | 5.84 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 749,000.00 |
| Dec 31, 2022 | 218,000.00 |
| Sep 30, 2022 | 192,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 19,000.00 |
API Access
Mineralys Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();